Bristol-Myers Squibb Company (BMY)

Tickers BMY, CELG-RI · SEC CIK 14272 · Latest fiscal year ended Dec 31, 2025

Bristol-Myers Squibb Company reported revenue of $48.19B for the fiscal year ended Dec 31, 2025, down 0.2% from $48.30B the year before. Net income was $7.05B, a net margin of 14.6% (prior year: −$8.95B). At the end of that fiscal year the company reported total assets of $90.04B and shareholders' equity of $18.47B.

Revenue

$48.19B

−0.2% vs prior year

Net income

$7.05B

Net margin 14.6%

Diluted EPS

$3.46

USD per share

Total assets

$90.04B

At Dec 31, 2025

Equity

$18.47B

At Dec 31, 2025

Shares outstanding

2,044M

As of Oct 21, 2026

Bristol-Myers Squibb Company annual revenue, USD. Hover a bar for the exact figure.

Explore Bristol-Myers Squibb Company's filings

Revenue by year — annual and quarterly revenue with growth rates
Income statement & cash flow — profit, margins, EPS and operating cash flow
Balance sheet — assets, liabilities, equity, cash and debt
SEC filings — 10-K and 10-Q filings with links to EDGAR

Latest SEC filings

Compare Bristol-Myers Squibb Company

ABBVABBV vs BMY

Source: SEC EDGAR XBRL company facts for CIK 14272 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.